Molecular Monitoring of RUNX1-RUNX1T1 Transcript Level in Acute Myeloblastic Leukemias on Treatment

Molecular Monitoring of RUNX1-RUNX1T1 Transcript Level in Acute Myeloblastic Leukemias on Treatment

Background. The current approach to treatment of acute myeloblastic leukemia (AML) includes the achievement of maximum tumor reduction and, therefore, eradication of a leukemic clone. The goal of the therapy is to achieve undetectable levels of the target gene, except an isolated molecular rearrange...

Full description

Saved in:
Bibliographic Details
Main Authors: LL Girshova, EG Ovsyannikova, SO Kuzin, EN Goryunova, RI Vabishchevich, AV Petrov, DV Motorin, DV Babenetskaya, VV Ivanov, KV Bogdanov, IV Kholopova, TS Nikulina, YuV Mirolyubova, YuA Alekseeva, AYu Zaritskii
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2016-10-01
Series:Клиническая онкогематология
Subjects:
acute myeloblastic leukemia
AML
RUNX1-RUNX1T1
molecular monitoring
Online Access:http://bloodjournal.ru/en/molecular-monitoring-of-runx1-runx1t1-transcript-level-in-acute-myeloblastic-leukemias-on-treatment/
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://bloodjournal.ru/en/molecular-monitoring-of-runx1-runx1t1-transcript-level-in-acute-myeloblastic-leukemias-on-treatment/

Similar Items